299 related articles for article (PubMed ID: 10412681)
1. Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy.
Rogala B; Glück J
J Investig Allergol Clin Immunol; 1999; 9(3):183-9. PubMed ID: 10412681
[TBL] [Abstract][Full Text] [Related]
2. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
3. Effect of specific immunotherapy on IgE immune complexes in seasonal allergic rhinitis.
Rogala B; Jarzab J; Karawajczyk M; Jawor B; Rogala E
Pneumonol Alergol Pol; 1992; 60 Suppl 1():57-62. PubMed ID: 1292849
[No Abstract] [Full Text] [Related]
4. [Platelet aggregation test in specific immunotherapy].
Rogala B; Gumprecht J
Pneumonol Alergol Pol; 1999; 67(3-4):126-36. PubMed ID: 10497445
[TBL] [Abstract][Full Text] [Related]
5. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
6. [Circulating immune complexes in patients treated with Pollinex vaccine].
Wrzyszcz M; Małolepszy J; Krasnowska M; Liebhart E; Medrala W; Kopeć W
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):737-9. PubMed ID: 2128120
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
8. [Effect of immunotherapy on selected immunologic indices in children with pollinosis].
Boznański A; Pirogowicz I; Widerska A; Hebrowska A
Pediatr Pol; 1996 Jan; 71(1):15-8. PubMed ID: 8966061
[TBL] [Abstract][Full Text] [Related]
9. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
10. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
11. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
12. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
13. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
[TBL] [Abstract][Full Text] [Related]
16. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
17. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Mar; 133(3):261-6. PubMed ID: 14976395
[TBL] [Abstract][Full Text] [Related]
19. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]